These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26381996)

  • 21. Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
    Döring M; Eikemeier M; Cabanillas Stanchi KM; Hartmann U; Ebinger M; Schwarze CP; Schulz A; Handgretinger R; Müller I
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1189-200. PubMed ID: 25680318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multidisciplinary team approach to the management of patients with suspected or diagnosed invasive fungal disease.
    Ben-Ami R; Halaburda K; Klyasova G; Metan G; Torosian T; Akova M
    J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii25-33. PubMed ID: 24155143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.
    Doan TN; Kirkpatrick CM; Walker P; Slavin MA; Ananda-Rajah MR; Morrissey CO; Urbancic KF; Grigg A; Spencer A; Szer J; Seymour JF; Kong DC
    J Antimicrob Chemother; 2016 Feb; 71(2):497-505. PubMed ID: 26518050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antifungal Drugs in Newborns and Children.
    Puia-Dumitrescu M; Smith PB
    Pediatr Clin North Am; 2017 Dec; 64(6):1389-1402. PubMed ID: 29173792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of antifungal agents in neonates and young infants.
    Regazzi M; Billaud EM; Lefeuvre S; Stronati M
    Curr Med Chem; 2012; 19(27):4621-32. PubMed ID: 22876899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit.
    Yunus S; Pieper S; Kolve H; Goletz G; Jürgens H; Groll AH
    J Antimicrob Chemother; 2014 Mar; 69(3):815-20. PubMed ID: 24198097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
    Maertens J
    Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rationale for reduced-frequency dosing of anidulafungin for antifungal prophylaxis in immunocompromised patients.
    Brüggemann RJ; Van Der Velden WJ; Knibbe CA; Colbers A; Hol S; Burger DM; Donnelly JP; Blijlevens NM
    J Antimicrob Chemother; 2015 Apr; 70(4):1166-74. PubMed ID: 25473029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An update on pediatric invasive aspergillosis.
    Frange P; Bougnoux ME; Lanternier F; Neven B; Moshous D; Angebault C; Lortholary O; Blanche S
    Med Mal Infect; 2015 Jun; 45(6):189-98. PubMed ID: 26026226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive fungal infections in the oncology patient: an overview of clinical manifestations and treatment.
    ONS News; 2004; 19(9 Suppl):21-2. PubMed ID: 15478572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial.
    Santolaya ME; Alvarez AM; Acuña M; Avilés CL; Salgado C; Tordecilla J; Varas M; Venegas M; Villarroel M; Zubieta M; Farfán M; de la Maza V; Vergara A; Valenzuela R; Torres JP
    J Antimicrob Chemother; 2018 Oct; 73(10):2860-2866. PubMed ID: 30010931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of management strategies in reducing mortality from invasive fungal disease in children with cancer or receiving hemopoietic stem cell transplant: a single center 30-year experience.
    Castagnola E; Bagnasco F; Amoroso L; Caviglia I; Caruso S; Faraci M; Calvillo M; Moroni C; Bandettini R; Cangemi G; Magnano GM; Buffa P; Moscatelli A; Haupt R
    Pediatr Infect Dis J; 2014 Mar; 33(3):233-7. PubMed ID: 24136371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy.
    Heng SC; Slavin MA; Al-Badriyeh D; Kirsa S; Seymour JF; Grigg A; Thursky K; Bajel A; Nation RL; Kong DC
    J Antimicrob Chemother; 2013 Jul; 68(7):1669-78. PubMed ID: 23485723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients.
    Science M; Robinson PD; MacDonald T; Rassekh SR; Dupuis LL; Sung L
    Pediatr Blood Cancer; 2014 Mar; 61(3):393-400. PubMed ID: 24424789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A practical critique of antifungal treatment guidelines for haemato-oncologists.
    Agrawal S; Jones B; Barnes R; Kibbler C; Millen M; Ashcroft M; Jain S; Last A; Lewis D; Lewis T; Patel M; Pagliuca A
    Crit Rev Microbiol; 2012 Aug; 38(3):203-16. PubMed ID: 22324737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal treatment in pediatric patients.
    Zaoutis TE; Benjamin DK; Steinbach WJ
    Drug Resist Updat; 2005 Aug; 8(4):235-45. PubMed ID: 16054422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
    Sohn HS; Lee TJ; Kim J; Kim D
    Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal therapy in children with invasive fungal infections: a systematic review.
    Blyth CC; Palasanthiran P; O'Brien TA
    Pediatrics; 2007 Apr; 119(4):772-84. PubMed ID: 17403849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment and timing in invasive mould disease.
    Maertens J; Groll AH; Cordonnier C; de la Cámara R; Roilides E; Marchetti O
    J Antimicrob Chemother; 2011 Jan; 66 Suppl 1():i37-43. PubMed ID: 21177402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.